Published in Cancer Weekly, April 19th, 2005
The finding sheds some light on the powerful, but little understood, workings of the NK T cells and will help scientists explore their possible use in fighting tumors and dangerous disease-causing bacteria.
In a paper, "Recognition of bacterial glycosphingolipids by natural killer T cells," published March 24 in the journal Nature, Mitchell Kronenberg, PhD, and an international team of scientists working at the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.